ReShape Lifesciences Inc Asset Resilience Ratio
ReShape Lifesciences Inc asset resilience ratio. ReShape Lifesciences Inc (RSLS) has an Asset Resilience Ratio of 5.51% as of December 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ReShape Lifesciences Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of ReShape Lifesciences Inc (2006–2018)
Asset resilience ratio of ReShape Lifesciences Inc from 2006 to 2018. This chart shows how ReShape Lifesciences Inc's Asset Resilience Ratio has changed over time. Read debt load of ReShape Lifesciences Inc for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down ReShape Lifesciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ReShape Lifesciences Inc total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $2.55 Million | 5.51% |
| Total Liquid Assets | $2.55 Million | 5.51% |
Asset Resilience Insights
- Limited Liquidity: ReShape Lifesciences Inc maintains only 5.51% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ReShape Lifesciences Inc Industry Peers by Asset Resilience Ratio
Compare ReShape Lifesciences Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
ReShape Lifesciences Inc Asset Resilience Ratio by Year (2006–2018)
ReShape Lifesciences Inc asset resilience ratio by year from 2006 to 2018. The table below shows the annual Asset Resilience Ratio data for ReShape Lifesciences Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-12-31 | 5.51% | $2.55 Million | $46.27 Million | -20.75pp |
| 2017-12-31 | 26.26% | $23.29 Million | $88.70 Million | -9.25pp |
| 2016-12-31 | 35.51% | $2.50 Million | $7.04 Million | -43.68pp |
| 2015-12-31 | 79.18% | $9.18 Million | $11.59 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $14.39 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $26.39 Million | -- |
| 2012-12-31 | 0.77% | $200.00K | $26.10 Million | -2.33pp |
| 2011-12-31 | 3.09% | $1.01 Million | $32.49 Million | -13.78pp |
| 2010-12-31 | 16.87% | $6.53 Million | $38.69 Million | -1.66pp |
| 2008-12-31 | 18.53% | $5.24 Million | $28.28 Million | +4.48pp |
| 2007-12-31 | 14.05% | $8.30 Million | $59.05 Million | -33.63pp |
| 2006-12-31 | 47.68% | $17.20 Million | $36.06 Million | -- |
About ReShape Lifesciences Inc
As of August 14, 2025, ReShape Lifesciences Inc. was acquired by Vyome Therapeutics Inc., in a reverse merger transaction. ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System to treat obesity and invasive surgical stapling… Read more